Abstract
The aim was to analyze the clinical outcome of a group of 51 patients diagnosed with systemic amyloidosis associated with rheumatoid arthritis who received hemodialysis (HD) as renal replacement therapy. We monitored the clinical course of the disease and factors that could influence survival. Determination of the onset of the underlying disorder was made retrospectively by reviewing the patient’s chart when a diagnosis of amyloid was confirmed. During a 96.9 person-year follow-up, 42 patients died. Survival of these 51 patients from the initiation of HD at 251 days was 50%. Poor prognosis in amyloid patients was mainly due to a large number of sudden deaths immediately following HD therapy. Out of 51 patients 21 needed unplanned initiation of HD. The unplanned initiation was significantly associated with poor survival. Seventy-five percentile of creatinine clearance (Ccr) was 9.7 ml/min, and 75% of these patients who initiated HD had highly impaired renal functional states. These data indicated that amyloidotic patients with HD showed a high mortality rate; therefore, planned initiation of HD was highly recommended to improve the patient’s survival. Particular attention was given to the Ccr levels, because the levels of serum creatinine may not be a useful marker for some patients with amyloidosis.
Similar content being viewed by others
References
Glenner GG (1980) Amyloid deposits and amyloidosis: The β-fibrillosis. N Engl J Med 302:1283–1292
Suzuki A, Ohoshone Y, Obana M, Mita S, Matsuoka Y, Irimajiri S, Fukuda J (1994) Cause of death in 81 autopsied patients with rheumatoid arthritis. J Rheumatol 21:33–36
Rocken C, Shakespeare A (2002) Pathology, diagnosis and pathogenesis of AA amyloidosis. Virchows Arch 440:111–122
Kobayashi H, Tada S, Fuchigami T, Okuda Y, Takasugi K, Matsumoto T, Iida M, Aoyagi K, Iwashita A, Daimaru Y, Fujishima M (1996) Secondary amyloidiosis in patients with rheumatoid arthritis: diagnostic and prognostic value of gastroduodenal biopsy. Br J Rheumatol 35:44–49
Husby G (1985) Amyloidosis and rheumatoid arthritis. Clin Exp Rheumatol 3:173–180
Kuroda T, Tanabe N, Sakatsume M, Nozawa S, Mituska T, Ishikawa H, Tohyama CT, Nakazono K, Murasawa A, Nakano M, Gejyo F (2002) Comparison of gastroduodenal, renal and abdominal fat biopsies for diagnosing amyloidosis in rheumatoid arthritis. Clin Rheumatol 21:123–128
Breedveld FC, Markusse HM, MacFarlane JD (1989) Subcutaneous fat biopsy in the diagnosis of amyloid secondary to chronic arthritis. Clin Exp Rheumatol 7:407–410
Sorsa S, Happonen RP, Klemi P (1988) Oral biopsy and fine needle aspiration biopsy from subcutaneous fat in diagnosis of secondary amyloidosis. Int J Oral Maxillofac Surg 17:14–16
Tada S, Iida M, Iwashita A, Matsui T, Fuchigami T, Yamamoto T, Yao T, Fujishima M (1990) Endoscopic and biopsy findings of the upper digestive tract in patients with amyloidosis. Gastrointest Endosc 36:10–14
Mutru O, Laakso M, Isomaki H, Koota K (1985) Ten-year mortality and cause of death in patients with rheumatoid arthritis. Br Med J 290:1797–1799
Rally PA, Cosh JA, MaddisonPJ, Rasker JJ, Silman AJ (1990) Mortality and survival in rheumatoid arthritis: a 25-year prospective study of 100 patients. Ann Rheum Dis 49:363–369
Mutru O, Koota K, Isomaki HA (1976) Cause of death in autopsied rheumatoid arthritis patients. Scand J Rheumatol 5:239–240
Arnett FC, Edworthy SM, Bloch AD, McShane DJ, Fries JF, Cooper NS Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger Jr. TA, Mitchell DM, Neustadt DH, Pinals RS, Schaller PJ, Sharp JT, Wilder RL, Hunder GG (1988) The American Rheumatism Association 1987 revised criteria for the classification of Rheumatoid arthritis. Arthritis Rheum 31:315–324
Steinbrocker O, Traeger CH, Betteman RC (1949) Therapeutic criteria in rheumatoid arthritis. JAMA 140:659–662
Kyle RA, Gertz MA. Amyloidosis; in Massry SG, Glassock RJ (eds) (1989) Textbook of nephrology. Williams & Wilkins, Baltimore, vol 1, pp 745–750
Martinez-Vea A, Garcia C, Carreras M, Revert L, Oliver JA (1990) End-stage renal disease in systemic amyloidosis: clinical course and outcome on dialysis. Am J Nephrol 10:283–289
Ylinen K, Gronhagen-Riska C, Honkanen E, Ekstrand A, Metsarinne K, Kuhlback B (1992) Outcome of patients with secondary amyloidosis in dialysis treatment. Nephrol Dial Transplant 79:908–912
Hezemans RL, Krediet RT, Arisz L (1995) Dialysis treatment in patients with rheumatoid arthritis. Neth J Med 47:6–11
Lowrie EG, Lew NL (1990) Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15:458–482
Acchiardo SR, Moore LW, Latour PA (1983) Malnutrition as the main factor in morbidity and mortality of hemodialysis patients. Kidney Int Suppl 16:S199–S203
Patient Registration Committee, Japanese Society for Dialysis Therapy (2004) An overview of regular dialysis treatment in Japan (as of 31 December 2001). Ther Apher Dial 8:3–32
Moriguchi M, Terai C, Koseki Y, Uesato M, Kamatani N (2000) Renal function estimated from serum creatinine is overestimated in patients with rheumatoid arthritis because of their muscle atrophy. Mod Rheumatol 10:230–234
Steele TE, Baltimore D, Finkelstein SH, Juergensen P, Kliger AS, Finkelstein FO (1996) Quality of life in peritoneal dialysis patients. J Nerv Ment Dis 184:368–374
Anelli MG, Torres DD, Manno C, Scioscia C, Iannone F, Covelli M, Schena FP, Lapadula G (2005) Improvement of renal function and disappearance of hepatitis B virus DNA in a patient with rheumatoid arthritis and renal amyloidosis following treatment with infliximab. Arthritis Rheum 52:2519–2520
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kuroda, T., Tanabe, N., Sato, H. et al. Outcome of patients with reactive amyloidosis associated with rheumatoid arthritis in dialysis treatment. Rheumatol Int 26, 1147–1153 (2006). https://doi.org/10.1007/s00296-006-0204-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-006-0204-6